Skip to main content

Articles

Resource Utilization for Chemotherapy-Induced Nausea and Vomiting Events in Patients with Solid Tumors Treated with Antiemetic Regimens
Stakeholder Perspective
Impact of Chemotherapy-Induced Nausea and Vomiting Treatment on Patient Outcomes and Resource Utilization
Read More
Value-Based Healthcare Delivery: The Agenda for Oncology
Read More
FDA Approvals
Nivolumab Beats Docetaxel as Second-Line Therapy for Patients with NSCLC
Read More
Searching for the Tipping Point in Drug Pricing
Read More
FDA Approvals
Oncology Pipeline Full, and Not Just with Immunotherapies
Read More
FDA Approvals
FDA Update
Read More
Aetna Examines Impact of Site of Service on Chemotherapy Cost
Read More
Treating with Checkpoint Inhibitors—Figure $1 Million per Patient
Read More
Researchers Dissect the Cost of Targeted Agents
Read More
Bevacizumab Wins Cost-Effectiveness Contest in First-Line Metastatic Colorectal Cancer
Read More
Page 128 of 244
Results 1271 - 1280 of 2439